glycine has been researched along with Biliary Tract Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelakas, A | 1 |
| Lamarca, A | 1 |
| Hubner, RA | 1 |
| McNamara, MG | 1 |
| Valle, JW | 1 |
| Ollila, S | 1 |
| Dermadi Bebek, D | 1 |
| Greenblatt, M | 1 |
| Nyström, M | 1 |
1 review available for glycine and Biliary Tract Cancer
| Article | Year |
|---|---|
Ivosidenib: an investigational drug for the treatment of biliary tract cancers.
Topics: Antineoplastic Agents; Bile Duct Neoplasms; Biliary Tract Neoplasms; Cholangiocarcinoma; Drugs, Inve | 2021 |
1 other study available for glycine and Biliary Tract Cancer
| Article | Year |
|---|---|
Uncertain pathogenicity of MSH2 variants N127S and G322D challenges their classification.
Topics: Asparagine; Aspartic Acid; Biliary Tract Neoplasms; Blotting, Western; Colorectal Neoplasms, Heredit | 2008 |